Enliven Therapeutics, Inc. (ELVN) vs Xenon Pharmaceuticals Inc. (XENE)

Enliven Therapeutics, Inc. and Xenon Pharmaceuticals Inc. are both Biotechnology companies. Xenon Pharmaceuticals Inc. is the larger, with a market value of $3.7B against $3.3B — 1.1× the size. Across the 10 metrics below, Enliven Therapeutics, Inc. leads on 7 and Xenon Pharmaceuticals Inc. on 3.

Valuation

Metric ELVN XENE Biotechnology median
P/E n/m n/m 7.88
P/S n/m 217.29 11.47
P/B 3.31 2.96 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 162.98 10.73
Earnings yield (3.73%) (12.83%) (28.84%)
Free cash flow yield (2.26%) (9.20%) (23.03%)

Profitability

Metric ELVN XENE Biotechnology median
Gross margin 0.00% 28.40% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (15.31%) (43.62%) (57.72%)
Return on assets (14.98%) (41.54%) (49.22%)
Return on invested capital 0.00% (88.54%) 0.00%

Growth

Metric ELVN XENE Biotechnology median
Revenue growth (TTM) — (8.15%) 5.64%
EPS growth (last fiscal year) 3.17% (44.85%) —
Revenue growth, 5-year CAGR — 89.00% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ELVN XENE Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 64.07 21.02 4.73
Net debt to EBITDA 3.87 1.48 0.96

Dividend

Metric ELVN XENE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ELVN XENE Biotechnology median
Market cap 3.31b 3.73b 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack